Perceiva sirolimus: Completed Phase II enrollment

By WIR Staff | Oct 5, 2009 | 7:00 AM GMT

MacuSight completed enrollment of 20 previously untreated patients

Read the full 87 word article

How to gain access

Continue reading with a
two-week free trial.